ClinConnect ClinConnect Logo
Search / Trial NCT06921733

Ultrasound Localization Microscopy in Patient With Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)

Launched by UNIVERSITY OF ERLANGEN-NÜRNBERG MEDICAL SCHOOL · Apr 3, 2025

Trial Information

Current as of August 25, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new imaging technique called Ultrasound Localization Microscopy (ULM) to better understand how blood flows in the kidneys of children with certain birth defects affecting the kidneys and urinary tract. These conditions, known as congenital anomalies of the kidney and urinary tract (CAKUT), can lead to problems like urinary blockage and swelling of the kidneys. The goal of the study is to visualize small blood vessels and kidney structures without any invasive procedures, which means it doesn’t require surgery or other uncomfortable methods.

To participate in this trial, children must be between 1 month and 6 years old and need to have a specific kidney test called MAG3 Scintigraphy due to their kidney condition. It's also important that at least one parent or guardian gives consent for their child to be involved in the study. While the trial is currently looking for participants, families can expect a supportive environment and detailed explanations of the process to ensure everyone feels comfortable and informed. This study could help doctors find better ways to treat children with kidney and urinary tract issues in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Minimum Age 1 Month Maximum Age 6 Years Indication for MAG3 Scintigraphy of the Kidney Congenital Anomalies of the Kidney and Urinary Tract Obstruction Diagnosis Availability of the qualified examiner Consent of the parents/legal guardians
  • Exclusion Criteria:
  • Lack of consent of at least one parent

About University Of Erlangen Nürnberg Medical School

The University of Erlangen-Nürnberg Medical School is a prestigious institution dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. Renowned for its interdisciplinary approach, the medical school fosters collaboration among experts in various fields, enabling the development of cutting-edge therapies and treatment protocols. With a commitment to ethical standards and patient safety, the institution actively contributes to the global medical community by conducting rigorous clinical studies aimed at enhancing the understanding and management of diverse health conditions.

Locations

Erlangen, Bavaria, Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported